Table 4 Comparison of two reports (Newman et al.) from the same population cohort on outcome of infants with extreme hyperbilirubinemia (TSB 25 and 30 mg per 100 ml)

From: Kernicterus in the 21st century: frequently asked questions

  Reported 2006 20 Reported 2003 19
Sample population Infants with TSB25 mg per 100 ml Infants with TSB 30 mg per 100 ml
Study period 1995–1998 1995–1998
Cohort size 106 627 111 009
Study infants with TSB >25 mg per 100 ml 140
Study infants with TSB >30 mg per 100 ml 10 11
Use of exchange and phototherapy 5 5
Use of phototherapy only 131 8
No reported interventions 4a 0
Signs of ABE 0 0
Number of infants followed a the age of 2 years 132/140
(94%)
SIDS=1; lost=2, speech therapy=1
Number of infants followed at the age of 5 years 82 (54%) None
  1. aDetails of outcome or follow-up were not reported for this high-risk group.